Einzeltreffer — DigiBib

Objective: To present the update of the recommendations of the Brazilian College of Radiology and Diagnostic Imaging, the Brazilian Society of Mastology and the Brazilian Federation of Associations of Gynecology and Obstetrics for breast cancer screening in Brazil.

Methods: Scientific evidence published in Medline, EMBASE, Cochrane Library, EBSCO, CINAHL and Lilacs databases between January 2012 and July 2022 was searched. Recommendations were based on this evidence by consensus of the expert committee of the three entities.

Recommendations: Annual mammography screening is recommended for women at usual risk aged 40-74 years. Above 75 years, it should be reserved for those with a life expectancy greater than seven years. Women at higher than usual risk, including those with dense breasts, with a personal history of atypical lobular hyperplasia, classic lobular carcinoma in situ, atypical ductal hyperplasia, treatment for breast cancer or chest irradiation before age 30, or even, carriers of a genetic mutation or with a strong family history, benefit from complementary screening, and should be considered individually. Tomosynthesis is a form of mammography and should be considered in screening whenever accessible and available.

Competing Interests: None to declare.

(Federação Brasileira de Ginecologia e Obstetrícia. This is an open access article published by Thieme under the terms of the Creative Commons Attribution License, permitting unrestricted use, distribution, and reproduction so long as the original work is properly cited. (https://creativecommons.org/licenses/by/4.0/).)

Titel:	Recommendations for the Screening of Breast Cancer of the Brazilian College of Radiology and Diagnostic Imaging, Brazilian Society of Mastology and Brazilian Federation of Gynecology and Obstetrics Association.
Autor/in / Beteiligte Person:	Urban, LABD ; Chala, LF ; Paula, IB ; Bauab, SDP ; Schaefer, MB ; Oliveira, ALK ; Shimizu, C ; Oliveira, TMG ; Moraes, PC ; Miranda, BMM ; Aduan, FE ; Rego, SJF ; Canella, EO ; Couto, HL ; Badan, GM ; Francisco, JLE ; Moraes, TP ; Jakubiak, RR ; Peixoto, JE
Link:	Zum Volltext
Zeitschrift:	Revista brasileira de ginecologia e obstetricia : revista da Federacao Brasileira das Sociedades de Ginecologia e Obstetricia, Jg. 45 (2023-08-01), Heft 8, S. e480
Veröffentlichung:	2024- : São Paulo : Federação das Sociedades de Ginecologia e Obstetrícia ; <i>Original Publication</i>: [São Paulo, Brazil] : Medisa Editora, 2023
Medientyp:	academicJournal
ISSN:	1806-9339 (electronic)
DOI:	10.1055/s-0043-1772498
Schlagwort:	Female Humans Pregnancy Brazil Early Detection of Cancer Mammography Practice Guidelines as Topic Breast Neoplasms diagnostic imaging Obstetrics Radiology
Sonstiges:	Nachgewiesen in: MEDLINE Sprachen: English Transliterated Title: Recomendações para o rastreio do câncer de mama do colégio brasileiro de radiologia e diagnóstico por imagem, sociedade brasileira de mastologia e associação da federação brasileira de ginecologia e obstetrícia. Publication Type: Journal Article Language: English [Rev Bras Ginecol Obstet] 2023 Aug; Vol. 45 (8), pp. e480-e488. <i>Date of Electronic Publication: </i>2023 Sep 08. MeSH Terms: Breast Neoplasms* / diagnostic imaging ; Obstetrics* ; Radiology* ; Female ; Humans ; Pregnancy ; Brazil ; Early Detection of Cancer ; Mammography ; Practice Guidelines as Topic References: J Glob Oncol. 2019 Nov;5:1-10. (PMID: 31730380) ; Radiol Bras. 2017 Jul-Aug;50(4):244-249. (PMID: 28894332) ; AJR Am J Roentgenol. 2011 Feb;196(2):W112-6. (PMID: 21257850) ; Eur Radiol. 2017 Jul;27(7):2737-2743. (PMID: 27807699) ; JAMA Oncol. 2017 Nov 01;3(11):1495-1502. (PMID: 28655029) ; Eur J Hum Genet. 2020 Oct;28(10):1379-1386. (PMID: 32457520) ; J Am Coll Radiol. 2023 May 5;:. (PMID: 37150275) ; Breast Cancer Res Treat. 2017 Aug;164(3):557-569. (PMID: 28516226) ; Br J Cancer. 2016 Mar 15;114(6):631-7. (PMID: 26908327) ; JAMA. 2014 Apr 2;311(13):1336-47. (PMID: 24691609) ; JAMA. 1992 Feb 19;267(7):941-4. (PMID: 1734106) ; Hum Pathol. 1991 Dec;22(12):1232-9. (PMID: 1748429) ; Breast J. 2007 Mar-Apr;13(2):115-21. (PMID: 17319851) ; JAMA. 2014 Jun 25;311(24):2499-507. (PMID: 25058084) ; Lancet. 2016 Jan 23;387(10016):341-348. (PMID: 26547101) ; J Natl Cancer Inst. 2020 Feb 1;112(2):136-144. (PMID: 31233143) ; JAMA Netw Open. 2021 Aug 2;4(8):e2121505. (PMID: 34406400) ; Cancer Prev Res (Phila). 2014 Feb;7(2):211-7. (PMID: 24480577) ; Ann Intern Med. 2016 Feb 16;164(4):205-14. (PMID: 26756460) ; Insights Imaging. 2023 Feb 6;14(1):27. (PMID: 36746832) ; N Engl J Med. 2019 Nov 28;381(22):2091-2102. (PMID: 31774954) ; Cancer. 2006 Sep 15;107(6):1240-7. (PMID: 16902983) ; Lancet Oncol. 2013 Dec;14(13):e621-9. (PMID: 24275135) ; J Clin Oncol. 2010 Dec 20;28(36):5265-73. (PMID: 21079137) ; Stat Sci. 2020 Mar 3;35(1):14-30. (PMID: 32226220) ; Histopathology. 2010 Aug;57(2):171-92. (PMID: 20500230) ; Sci Rep. 2022 Mar 9;12(1):4190. (PMID: 35264596) ; AJR Am J Roentgenol. 2020 Mar;214(3):701-706. (PMID: 31613659) ; Springerplus. 2015 Aug 28;4:459. (PMID: 26322264) ; JAMA Oncol. 2017 Jan 01;3(1):36-41. (PMID: 27607465) ; J Clin Oncol. 2012 Aug 1;30(22):2745-52. (PMID: 22734026) ; J Breast Imaging. 2020 Feb;2(1):29-35. (PMID: 32055796) ; Can Assoc Radiol J. 2022 Feb;73(1):101-106. (PMID: 34134531) ; Radiographics. 2023 May;43(5):e220166. (PMID: 37053102) ; Clin Breast Cancer. 2021 Aug;21(4):278-291. (PMID: 33846098) ; BMC Cancer. 2018 Apr 3;18(1):380. (PMID: 29615072) ; Radiology. 2019 Jul;292(1):51-59. (PMID: 31063080) ; Breast. 2019 Apr;44:113-119. (PMID: 30738289) ; Br J Cancer. 2018 Jun;118(12):1559-1570. (PMID: 29736009) ; Radiology. 2014 Aug;272(2):366-73. (PMID: 24635678) ; JAMA. 2012 Apr 4;307(13):1394-404. (PMID: 22474203) ; Breast J. 2015 Mar-Apr;21(2):175-80. (PMID: 25683369) ; Radiology. 2022 May;303(2):256-266. (PMID: 35103537) ; JAMA Oncol. 2015 Nov;1(8):1069-77. (PMID: 26501844) ; Radiology. 2015 Mar;274(3):663-73. (PMID: 25329763) ; Lancet Oncol. 2019 Aug;20(8):1136-1147. (PMID: 31221620) ; J Natl Cancer Inst. 2021 Jun 1;113(6):680-690. (PMID: 33372954) ; Qual Life Res. 2022 Apr;31(4):1057-1068. (PMID: 34698976) ; JAMA Netw Open. 2020 Jul 1;3(7):e2011792. (PMID: 32721031) ; Radiology. 2019 Aug;292(2):311-318. (PMID: 31161975) ; Eur J Cancer. 2017 Nov;85:160. (PMID: 28870467) ; Cancer Epidemiol Biomarkers Prev. 2013 May;22(5):946-61. (PMID: 23513042) ; Lancet Oncol. 2022 May;23(5):601-611. (PMID: 35427470) ; J Med Screen. 2021 Dec;28(4):389-404. (PMID: 33632023) ; JAMA. 2015 Oct 20;314(15):1599-614. (PMID: 26501536) ; Radiology. 2020 Feb;294(2):256-264. (PMID: 31821118) ; JAMA Netw Open. 2022 Dec 1;5(12):e2244212. (PMID: 36454573) ; Acad Radiol. 2015 Nov;22(11):1331-7. (PMID: 26142951) ; Radiology. 2023 May;307(3):e221571. (PMID: 36916891) ; J Natl Cancer Inst. 2016 Jan 07;108(3):. (PMID: 26744477) Contributed Indexing: Local Abstract: [Publisher, Portuguese] Apresentar a atualização das recomendações do Colégio Brasileiro de Radiologia e Diagnóstico por Imagem da Sociedade Brasileira de Mastologia e da Federação Brasileira das Associações de Ginecologia e Obstetrícia para o rastreamento do câncer de mama no Brasil. MéTODOS: Foram pesquisadas evidências científicas publicadas nas bases de dados Medline EMBASE Biblioteca Cochrane EBSCO CINAHL e Lilacs entre janeiro de 2012 e julho de 2022. As recomendações foram baseadas nessas evidências por consenso do comitê de especialistas das três entidades. RECOMENDAçõES: A mamografia anual é recomendada para mulheres com risco habitual entre 40 e 74 anos. Acima de 75 anos deve ser reservado para aqueles com expectativa de vida superior a sete anos. Mulheres com risco maior do que o normal incluindo aquelas com mamas densas com história pessoal de hiperplasia lobular atípica carcinoma lobular in situ clássico hiperplasia ductal atípica tratamento para câncer de mama ou irradiação de tórax antes dos 30 anos ou ainda portadoras de doença genética mutação ou com forte histórico familiar beneficiam-se de triagem complementar e devem ser considerados individualmente. A tomossíntese é uma forma de mamografia e deve ser considerada na triagem sempre que acessível e disponível. Entry Date(s): Date Created: 20230908 Date Completed: 20230911 Latest Revision: 20230912 Update Code: 20240514 PubMed Central ID: PMC10491472

Klicken Sie ein Format an und speichern Sie dann die Daten oder geben Sie eine Empfänger-Adresse ein und lassen Sie sich per Email zusenden.

BibTeX Citavi, JabRef, u.a.
(Literaturverwaltung)

PDF kein Volltext!
(Merkzettel, Notizen)

RIS Endnote, Citavi u.a.
(Literaturverwaltung)

MODS
(XML zur Weiterverarbeitung)

oder

Wählen Sie das für Sie passende Zitationsformat und kopieren Sie es dann in die Zwischenablage, lassen es sich per Mail zusenden oder speichern es als PDF-Datei.

Gewünschter Zitations-Stil:

oder

Bitte prüfen Sie, ob die Zitation formal korrekt ist, bevor Sie sie in einer Arbeit verwenden. Benutzen Sie gegebenenfalls den "Exportieren"-Dialog, wenn Sie ein Literaturverwaltungsprogramm verwenden und die Zitat-Angaben selbst formatieren wollen.

Recommendations for the Screening of Breast Cancer of the Brazilian College of Radiology and Diagnostic Imaging, Brazilian Society of Mastology and Brazilian Federation of Gynecology and Obstetrics Association.